🟢 MetaVia is trading 10.32% up on November 4, 2026, amid U.S. stocks rallying after midterm results

MetaVia is trading at $1.39, up 10.32%, amid broad-market gains; no direct catalyst for the move is confirmed.

• AP reported gains across major U.S. stock indexes after the midterm election results.
• MetaVia is scheduled to present Phase 1 DA-1726 data at the Precision Liver Symposium on November 4. The announcement predates the session, and no source found directly links it to the intraday rise.